Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
https://www.globenewswire.com/news-release/2024/03/04/2839220/0/en/Sandoz-acquires-CIMERLI-business-from-Coherus-further-building-biosimilar-and-ophthalmology-leadership-in-US-market.html
Mar 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next